Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Laeknabladid ; 107(1): 24-27, 2021 Jan.
Article in Icelandic | MEDLINE | ID: mdl-33350396

ABSTRACT

Endometriosis is a chronic condition causing menstrual pain, irregular bleeding and infertility among women. Although usually in the pelvis, it can manifest in atypical places. We describe a 39-year old woman with a previous endometriosis diagnosis who presented three times on the second menstrual day with dyspnea and chest pain. Imaging showed right-sided pneumothorax on all three occasions. Thoraco-scopy revealed endometriosis-like lesions. Histology was suggestive of endometriosis. After treatment with chemical pleurodesis and hormonal suppression she has remained symptom-free. Diagnosis should be obtained by concomitant thoraco- and laparoscopy with biopsies to verify the disease and give a basis for appropriate treatment.


Subject(s)
Endometriosis , Pneumothorax , Adult , Endometriosis/complications , Endometriosis/diagnosis , Female , Humans , Lung/diagnostic imaging , Menstruation , Pneumothorax/diagnostic imaging , Pneumothorax/etiology
2.
Acta Anaesthesiol Scand ; 63(7): 879-884, 2019 08.
Article in English | MEDLINE | ID: mdl-30937908

ABSTRACT

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) treatment is generally offered in large tertiary cardiothoracic referral centres. Here we present the indications and outcome of venovenous-ECMO (VV-ECMO) treatment in a low-volume, geographically isolated single-centre in Iceland, a country of 350 000 inhabitants. Our hypothesis was that patient survival in such a centre can be similar to that at high-volume centres. METHODS: A retrospective study that included all patients treated with VV-ECMO in Iceland from 1991-2016 (n = 17). Information on demographics, indications and in-hospital survival was collected from patient charts and APACHE II and Murray scores were calculated. Information on long-term survival was collected from a centralized registry. RESULTS: Seventeen patients were treated with VV-ECMO (nine males, median age 33 years, range 14-74), the indication for 16 patients was severe acute respiratory distress syndrome, most often following pneumonia (n = 6), H1N1-infection (n = 3) or drowning (n = 2). Median APACHE-II and Murray-scores were 20 and 3.5, respectively, and median duration of VV-ECMO treatment was 9 days (range 2-40 days). In total 11 patients (64,7%) survived the treatment, with 10 patients (58,8%) surviving hospital discharge, all of who were still alive at long-term follow-up, with a median follow-up time of 9 years (August 15th, 2017). CONCLUSION: Venovenous-ECMO service can be provided in a low-volume and geographically isolated centre, like Iceland, with short- and long-term outcomes comparable to larger centres.


Subject(s)
Cardiac Surgical Procedures/statistics & numerical data , Extracorporeal Membrane Oxygenation/statistics & numerical data , Thoracic Surgical Procedures/statistics & numerical data , APACHE , Adolescent , Adult , Aged , Cardiac Surgical Procedures/methods , Drowning , Female , Follow-Up Studies , Hospital Mortality , Humans , Iceland , Male , Middle Aged , Pneumonia/complications , Registries , Respiratory Distress Syndrome/therapy , Retrospective Studies , Survival Analysis , Thoracic Surgical Procedures/methods , Young Adult
3.
Respir Med Case Rep ; 26: 165-167, 2019.
Article in English | MEDLINE | ID: mdl-30662828

ABSTRACT

Tuberculosis is a rare cause of acute respiratory distress syndrome (ARDS) and mortality rates are high in tuberculosis patients that need treatment with mechanical ventilation. Experience of the use of extracorporeal membrane oxygenation (ECMO) in such circumstances is scarce. We report the case of an 18 year old man where prolonged therapy (50 days) with extracorporeal membrane oxygenation (ECMO) allowed extensive lung damage from miliary tuberculosis to heal. The case reflects how challenging the diagnosis of tuberculosis may be and how difficult it is to reach adequate blood levels of anti-tuberculosis drugs while on ECMO. It's also an example of how indications for ECMO have been expanding the last years and that long term ECMO therapy is possible without serious complications.

4.
Ann Thorac Surg ; 103(2): 610-616, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27592601

ABSTRACT

BACKGROUND: Perfusion strategies during aortic surgery usually comprise hypothermic circulatory arrest (HCA), often combined with selective antegrade cerebral perfusion (SACP) or retrograde cerebral perfusion. Cerebral blood flow (CBF) is a fundamental parameter for which the optimal level has not been clearly defined. We sought to determine the CBF at a pump flow level of 6 mL/kg/min, previously shown likely to provide adequate SACP at 20°C in pigs. METHODS: Repeated positron emission tomography (PET) scans were used to quantify the CBF and glucose metabolism throughout HCA and SACP including cooling and rewarming. Eight pigs on cardiopulmonary bypass were assigned to either HCA alone (n = 4) or HCA+SACP (n = 4). The CBF was measured by repeated [15O]water PET scans from baseline to rewarming. The cerebral glucose metabolism was examined by [18F]fluorodeoxyglucose PET scans after rewarming to 37°C. RESULTS: Cooling to 20°C decreased the cortical CBF from 0.31 ± 0.06 at baseline to 0.10 ± 0.02 mL/cm3/min (p = 0.008). The CBF was maintained stable by SACP of 6 mL/kg/min during 45 minutes. After rewarming to 37°C, the mean CBF increased to 0.24 ± 0.07 mL/cm3/min, without significant differences between the groups at any time-point exclusive of the HCA period. The net cortical uptake (Ki) of [18F]fluorodeoxyglucose after rewarming showed no significant difference between the groups. CONCLUSIONS: Cooling autoregulated the CBF to 0.10 mL/cm3/min, and 45 minutes of SACP at 6 mL/kg/min maintained the CBF in the present model. Cerebral glucose metabolism after rewarming was similar in the study groups.


Subject(s)
Brain/diagnostic imaging , Cerebrovascular Circulation/physiology , Circulatory Arrest, Deep Hypothermia Induced/methods , Perfusion/methods , Positron-Emission Tomography/methods , Postoperative Complications/prevention & control , Regional Blood Flow , Animals , Aorta, Thoracic/surgery , Brain/blood supply , Brain/metabolism , Disease Models, Animal , Glucose/metabolism , Postoperative Complications/diagnosis , Reproducibility of Results , Swine , Vascular Surgical Procedures/adverse effects
5.
Laeknabladid ; 102(2): 71-6, 2016 Feb.
Article in Icelandic | MEDLINE | ID: mdl-26863252

ABSTRACT

OBJECTIVES: Acute type A aortic dissection is a life-threatening disease associated with significant morbidity and mortality. Treatment is challenging and requires emergency surgery. This study presents for the first time the short- and long-term outcome of acute type A aortic dissection repairs in Iceland. MATERIALS AND METHODS: A retrospective review of 45 patients (mean age 60.7 ± 13.9 years, 68.9% male) treated for type A aortic dissection at Landspitali University Hospital between 1992 and 2014. Data was gathered from medical records about known risk factors, presenting symptoms, type of procedure, complications and operative mortality. RESULTS: Out of 45 operations the majority (73.3%) was performed in the second half of the study period. Nearly all patients presented with chest pain and 46.7% were in shock on arrival. Malperfusion syndrome was apparent in 26.7% of cases. A variety of operative methods were used, including hypothermic circulatory arrest in 31.1% of the cases and one-third of patients needed aortic root replacement. Reoperation rate for postoperative bleeding was 29.3% and perioperative stroke occurred in 14.6% of patients. The 30-day mortality rate was 22.2% (10 patients) and 5- and 10-year survival was 71.4 ± 8.2% and 65.4 ± 9.4%, respectively. CONCLUSIONS: The short-term outcomes of surgical repair for acute type A aortic dissection in Iceland is comparable to neighbouring countries, including 30-day mortality and long-term survival. Complications, however, are common, especially reoperations for bleeding. 1Department of Cardiothoracic Surgery, Landspitali University Hospital, 2Faculty of Medicine, University of Iceland. KEY WORDS: Aortic dissection type A, aortic aneurysm, open heart surgery, complications, operative mortality, survival. Correspondence: Arnar Geirsson, arnarge@landspitali.is.


Subject(s)
Aortic Aneurysm/surgery , Aortic Dissection/surgery , Blood Vessel Prosthesis Implantation , Acute Disease , Aortic Dissection/diagnostic imaging , Aortic Dissection/mortality , Aortic Aneurysm/diagnostic imaging , Aortic Aneurysm/mortality , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/mortality , Female , Hospitals, University , Humans , Iceland , Male , Medical Records , Middle Aged , Postoperative Hemorrhage/etiology , Postoperative Hemorrhage/mortality , Postoperative Hemorrhage/surgery , Reoperation , Retrospective Studies , Risk Factors , Stroke/etiology , Stroke/mortality , Survival Analysis , Time Factors , Treatment Outcome
6.
Eur J Cardiothorac Surg ; 44(3): e239-44, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23766424

ABSTRACT

OBJECTIVES: Superior venous outflow obstruction affects cerebral perfusion negatively by reducing cerebral perfusion pressure (CPP). We present a randomized study designed to compare two alternative strategies to preserve the CPP during superior vena cava (SVC) congestion and cardiopulmonary bypass (CPB). METHODS: Fourteen pigs on bi-caval CPB were subjected to 75% occlusion of the SVC flow. CPP was restored either by vasopressor treatment (VP, n = 7) or by partial relief (PR) of the congestion (n = 7). The cerebral effects of the interventions were studied for 60 min with intracranial pressure (ICP) monitoring, cerebral blood flow measurement, the near-infrared light spectroscopy tissue oxygen saturation index (StO2), arterial and venous blood gas analyses and serial measurements of the glial cell damage marker protein S100ß. RESULTS: Both strategies restored the CPP to baseline levels and no signs of severe ischaemia were observed. In the PR group, the venous and ICPs were normalized in response to the intervention, while in the VP group those parameters remained elevated throughout the experiment. The haemoglobin oxygen saturation in the sagittal sinus (SsagO2) was increased by both VP and PR, while significant improvement in the StO2 was observed only in the PR group. The S100ß concentrations were similar in the two groups. CONCLUSIONS: Experimental SVC obstruction during CPB may reduce the CPP, resulting in impaired cerebral perfusion. Both vasopressor treatment and improved venous drainage can, in the short term, individually restore the CPP during these circumstances.


Subject(s)
Cardiopulmonary Bypass/methods , Superior Vena Cava Syndrome/drug therapy , Vasoconstrictor Agents/pharmacology , Animals , Central Venous Pressure/drug effects , Central Venous Pressure/physiology , Cerebrovascular Circulation/drug effects , Cerebrovascular Circulation/physiology , Intracranial Pressure/drug effects , Intracranial Pressure/physiology , Norepinephrine/pharmacology , Oxygen/blood , Random Allocation , S100 Calcium Binding Protein beta Subunit/blood , Spectroscopy, Near-Infrared , Superior Vena Cava Syndrome/physiopathology , Swine
7.
J Thorac Oncol ; 6(11): 1833-40, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22011649

ABSTRACT

INTRODUCTION: Non-small cell lung cancer (NSCLC) is characterized by a multitude of genetic aberrations with unknown clinical impact. In this study, we aimed to identify gene copy number changes that correlate with clinical outcome in NSCLC. To maximize the chance to identify clinically relevant events, we applied a strategy involving two prognostically extreme patient groups. METHODS: Short-term (<20 month; n = 53) and long-term survivors (>58 month; n = 47) were selected from a clinically well-characterized NSCLC patient cohort with available fresh frozen tumor specimens. The samples were analyzed using high-resolution single-nucleotide polymorphism array technology to assess gene copy number variations and array-based gene expression profiling. The molecular data were combined with information on clinical parameters. RESULTS: Genetic aberrations were strongly associated with tumor histology. In adenocarcinoma (n = 50), gene copy number gains on chromosome 8q21-q24.3 (177 genes) were more frequent in long-term than in short-term survivors. In squamous cell carcinoma (n = 28), gains on chromosome 14q23.1-24.3 (133 genes) were associated with shorter survival, whereas losses in a neighboring region, 14q31.1-32.33 (110 genes), correlated with favorable outcome. In accordance with copy number gains and losses, messenger RNA expression levels of corresponding genes were increased or decreased, respectively. CONCLUSION: Comprehensive tumor profiling permits the integration of genomic, histologic, and clinical data. We identified gene copy number gains and losses, with corresponding changes in messenger RNA levels that were associated with prognosis in adenocarcinoma and squamous cell carcinoma of the lung.


Subject(s)
Carcinoma, Non-Small-Cell Lung/genetics , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Non-Small-Cell Lung/pathology , Chromosome Aberrations , Chromosomes, Human/genetics , Gene Dosage , Adenocarcinoma/genetics , Adenocarcinoma/mortality , Adenocarcinoma/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Large Cell/genetics , Carcinoma, Large Cell/mortality , Carcinoma, Large Cell/pathology , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , DNA, Neoplasm/genetics , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Humans , Lung Neoplasms/genetics , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Male , Microarray Analysis , Middle Aged , Neoplasm Staging , Polymorphism, Single Nucleotide , Prognosis , Real-Time Polymerase Chain Reaction , Survival Rate , Survivors
8.
Interact Cardiovasc Thorac Surg ; 11(5): 561-6, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20696750

ABSTRACT

To investigate the effects on cerebral perfusion by experimental venous congestion of the superior vena cava (SVC) during bicaval cardiopulmonary bypass (CPB) at 34 °C, pigs were subjected to SVC obstruction at levels of 75%, 50%, 25% and 0% of baseline SVC flow at two arterial flow levels (low, LQ, high, HQ). The cerebral perfusion was examined with near-infrared spectroscopy (NIRS), cerebral microdialysis and blood gas analysis. SVC obstruction caused significant decreases in the NIRS tissue oxygenation index (TOI) and in SVC oxygen saturations (P<0.05, both groups), while the mixed venous saturation was decreased only in the LQ group. Sagittal sinus venous saturations were measured in the HQ group and found significantly reduced in response to venous congestion (P<0.05). No microdialysis changes were seen at the group level, however, individual ischemic patterns in terms of concomitant venous desaturation, decreased TOI and increased lactate/pyruvate occurred in both groups. The total venous drainage remained stabile throughout the experiment, indicating increased flow in the inferior vena cava cannula. The results indicate that SVC congestion may impair cerebral perfusion especially in the case of compromised arterial flow during CPB. Reduced SVC cannula flow may pass undetected during bicaval CPB, if SVC flow is not specifically monitored.


Subject(s)
Brain Ischemia/etiology , Cardiopulmonary Bypass/adverse effects , Cerebrovascular Circulation , Monitoring, Intraoperative , Superior Vena Cava Syndrome/complications , Animals , Biomarkers/blood , Blood Gas Analysis , Blood Glucose/metabolism , Brain Ischemia/blood , Brain Ischemia/physiopathology , Central Venous Pressure , Disease Models, Animal , Glycerol/blood , Hypothermia, Induced , Lactic Acid/blood , Microdialysis , Monitoring, Intraoperative/methods , Oxygen/blood , Pyruvic Acid/blood , Regional Blood Flow , Spectroscopy, Near-Infrared , Superior Vena Cava Syndrome/blood , Superior Vena Cava Syndrome/physiopathology , Swine , Vena Cava, Inferior/physiopathology
9.
Interact Cardiovasc Thorac Surg ; 8(6): 647-53, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19324918

ABSTRACT

Hypothermic arrest and selective antegrade cerebral perfusion (SACP) is widely used during aortic arch surgery. The microdialysis technique monitors biomarkers of cellular metabolism and cellular integrity over time. In this study, the cerebral changes during hypothermic circulatory arrest (HCA) at 20 degrees C and HCA with SACP at two different temperatures, 20 and 28 degrees C, were monitored. Twenty-three pigs were divided into three groups. A microdialysis probe was fixated into the forebrain. Circulatory arrest started at a brain and body temperature of 20 degrees C or 28 degrees C. Arrest with/without cerebral perfusion (flow 10 ml/kg, max carotid artery pressure 70 mmHg) lasted for 80 min followed by reperfusion and rewarming during 40 min and an observation period of 120 min. The microdialysis markers were registered at six time-points. The lactate/pyruvate ratio (L/P ratio) and the lactate/glucose ratio (L/G ratio) increased significantly (P<0.05), during arrest, in the HCA group. The largest increase of glycerol was found in the group with tepid cerebral perfusion (28 degrees C) and the HCA group (P<0.05). This study supports the use of SACP over arrest. It also suggests that cerebral metabolism and cellular membrane integrity may be better preserved with SACP at 20 degrees C compared to 28 degrees C.


Subject(s)
Body Temperature , Cerebrovascular Circulation , Circulatory Arrest, Deep Hypothermia Induced , Microdialysis , Perfusion/methods , Prosencephalon/metabolism , Animals , Biomarkers/cerebrospinal fluid , Cardiopulmonary Bypass , Circulatory Arrest, Deep Hypothermia Induced/adverse effects , Energy Metabolism , Glucose/cerebrospinal fluid , Glycerol/cerebrospinal fluid , Lactic Acid/cerebrospinal fluid , Models, Animal , Monitoring, Intraoperative , Perfusion/adverse effects , Prosencephalon/pathology , Pyruvic Acid/cerebrospinal fluid , Sus scrofa , Time Factors
10.
Scand Cardiovasc J ; 43(4): 233-9, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19165645

ABSTRACT

OBJECTIVES: The Impella recovery axial-flow system is a mechanical assist system for use in acute heart failure. This retrospective study reports the use of the device at three cardiothoracic units in Sweden. DESIGN: Fifty patients (35 men, mean age 55.8 years, range 26 to 84 years) underwent implantation of 26 ImpellaLP 2.5/5.0 (support-time 0.1 to 14 days), 16 ImpellaLD (support-time 1 to 7 days) and 8 ImpellaRD (support-time 0.1 to 8 days) between 2003 and 2007. Implantation was performed because of postcardiotomy heart failure (surgical group, n=33) or for various states of heart failure in cardiological patients (non-surgical group, n=17). The intention for the treatments was mainly to use the pump as a "bridge-to-recovery". RESULTS: Early mortality in the surgical and non-surgical groups was 45% and 23%, respectively. Complications included infection, 36% and right ventricular failure, 28%. Cardiac output and cardiac power output postoperatively were significantly higher among survivors than non-survivors. CONCLUSIONS: The Impella recovery axial-flow system facilitates treatment in acute heart failure. Early intervention in patients with acute heart failure and optimized hemodynamics in the post-implantation period seem to be of importance for long-term survival. Insufficient early response to therapy should urge to consider further treatment options.


Subject(s)
Heart Failure/therapy , Heart-Assist Devices , Acute Disease , Adult , Aged , Aged, 80 and over , Cardiac Surgical Procedures/adverse effects , Equipment Design , Female , Heart Failure/etiology , Heart Failure/mortality , Heart Failure/physiopathology , Heart-Assist Devices/adverse effects , Hemodynamics , Hospital Mortality , Humans , Male , Middle Aged , Recovery of Function , Retrospective Studies , Risk Factors , Sweden/epidemiology , Time Factors , Treatment Outcome
11.
Lung Cancer ; 63(1): 16-22, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18571760

ABSTRACT

In the recent decade uniform treatment guidelines for non-small cell lung cancer (NSCLC) have been introduced in Sweden. The objective of this study was to examine time trends and differences in treatment intensity for NSCLC between county clinical centres in Central Sweden. A second aim was to investigate whether any differences in treatment of NSCLC were associated with differences in survival. 4345 patients with a diagnosis of NSCLC between 1995 and 2003 were identified in the population-based Lung Cancer Register of Central Sweden. Multivariate logistic regression was used to estimate odds ratios to analyse the likelihood of receiving different treatment modalities for NSCLC. Cox proportional hazard models estimating relative hazard ratios were used to identify factors related to death (by any cause). Of all patients, 33.4% received no treatment, and 17.5% underwent surgery. Between 1995 and 2003, the proportion of patients receiving chemotherapy rose from 14.6% to 55%. There were pronounced differences between county centres in treatment policies, especially concerning surgery and radiotherapy. The likelihood of receiving treatment for NSCLC was highest at county centre A where both surgical treatment and chemotherapy were given more often. Compared to this reference county, the risk of death was between 20% and 40% higher in the other counties after adjusting for age, stage, gender, time period, smoking status and histopathological type. When analyses were adjusted for treatment, county of residence was no longer a prognostic factor. Despite common guidelines there were marked differences in treatment activity between the counties. Treatment activity was associated with survival. Survival benefits may follow improvement in compliance to guidelines.


Subject(s)
Carcinoma, Non-Small-Cell Lung/epidemiology , Carcinoma, Non-Small-Cell Lung/therapy , Lung Neoplasms/epidemiology , Lung Neoplasms/therapy , Adult , Aged , Aged, 80 and over , Female , Humans , Likelihood Functions , Male , Medical Oncology/methods , Middle Aged , Regression Analysis , Risk Factors , Sweden , Treatment Outcome
13.
Ann Thorac Surg ; 75(2): 356-63, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12607639

ABSTRACT

BACKGROUND: Surgical resection is currently standard treatment in early stage lung cancer. The aim of the present study was to identify stage-related factors and patient characteristics influencing survival after complete resection. METHODS: We identified 395 patients with non-small cell lung cancer who had undergone potentially radical operation during 1987 to 1999 at one thoracic surgery institution in central Sweden. Factors independently related to survival were identified in a multivariate analysis. Survival was analyzed in low-, medium-, and high-risk groups based on a risk score calculated from relative hazards for identified risk factors. RESULTS: Overall 5-year survival among the 395 patients was 51%. The strongest factor predicting prognosis was positive lymph nodes at operation. Higher age, earlier period for operation, impaired lung function, current smoking, and major operative complication were all related to poorer prognosis. Patients with tumor stage Ia had a 5-year survival of 69%, compared to 73% in patients in the low-risk group. CONCLUSIONS: Tumor stage is the best prognostic indicator after radical operation. Inclusion of other tumor- and patient-related variables did not add prognostic information of clinical relevance beyond that provided by tumor stage alone.


Subject(s)
Carcinoma, Non-Small-Cell Lung/mortality , Lung Neoplasms/mortality , Adenocarcinoma/mortality , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Aged , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Non-Small-Cell Lung/surgery , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/surgery , Female , Humans , Lung Neoplasms/pathology , Lung Neoplasms/surgery , Lymphatic Metastasis , Male , Mediastinoscopy , Middle Aged , Multivariate Analysis , Neoplasm Staging , Prognosis , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL